SCHEMBL13359241

SCHEMBL13359241

COc1c(NC(=O)c2cc3cccc(NC(=O)c4cncnc4)c3s2)cc(C(C)(C)C)cc1N[S+](C)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LYN P07948 1/20 0.55
▸ MAPK9 P45984 1/20 0.55
▸ MAPK14 Q16539 5/20 0.47
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MEN1 O00255 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ BRAF P15056 4/20 0.34
▸ LCK P06239 1/20 0.34
▸ KIT P10721 1/20 0.34
▸ SRC P12931 1/20 0.34
▸ BTK Q06187 1/20 0.33
▸ DHPS P49366 1/20 0.33
▸ GSK3A P49840 1/20 0.33
▸ HDAC3 O15379 2/20 0.33
▸ HDAC4 P56524 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13359264 0.87 LYN (0.59) LYNMAPK9MAPK14CYP1A2CYP2C9
SCHEMBL13359212 0.86 LYN (0.51) LYNMAPK9MAPK14MEN1KMT2A
SCHEMBL13797958 0.86 LYN (0.72) LYNMAPK9MAPK14BRAF
SCHEMBL13359286 0.81 MAPK14 (0.49) LYNMAPK9MAPK14CYP1A2CYP3A4
SCHEMBL13359141 0.80 LYN (0.45) LYNMAPK9MAPK14MEN1KMT2A
SCHEMBL13359163 0.79 ALDH1A1 (0.42) LYNMAPK9MAPK14MEN1HPGD
SCHEMBL3257628 0.78 LYN (0.72) LYNMAPK9MAPK14KMT2ABRAF
SCHEMBL13797956 0.77 LYN (0.69) LYNMAPK9MAPK14CYP1A2CYP3A4
SCHEMBL13797967 0.77 LYN (0.69) LYNMAPK9MAPK14CYP1A2CYP3A4
SCHEMBL13797953 0.77 LYN (0.71) LYNMAPK9MAPK14BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497278-B1 HETEROCYCLIC AMIDE DERIVATIVES AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2010-05-26 — — EP disclosed
Send feedback